文献速递消化系统肿瘤

胆道癌患者的临床诊疗路径:法国全国纵向队列研究

Clinical care pathways of patients with biliary tract cancer: A French nationwide longitudinal cohort study.
PubMed 文献 · Eur J Cancer · 2024-03-16

该研究分析法国国家医疗数据库2017年1月1日至2021年12月31日全部胆道癌住院患者,识别出姑息治疗、非治愈性治疗和治愈性治疗三条临床路径,分别占38.7%、38.9%和22.4%;学术中心、私立中心、半私立中心及高、中容量中心与治愈性治疗路径概率增加相关。

要点

  • 共识别19,825例新发胆道癌患者,38.7%为姑息治疗路径,38.9%为非治愈性治疗路径,22.4%为治愈性治疗路径。
  • 1200家治疗中心中,84%为低容量中心(<15例/年),11%为中容量中心(15-30例/年),5%为高容量中心(>30例/年)。
  • 学术中心、私立中心、半私立中心及高、中容量中心与治愈性治疗路径概率增加相关。

核心结论

  • 在可通过医疗政策改善的因素中,管理胆道癌的中心容量和类型强烈影响治愈性治疗的获取。

研究设计与样本

  • 分析法国国家医疗数据库2017年1月1日至2021年12月31日全部胆道癌住院患者。
  • 使用多项逻辑回归调整优势比(aOR)识别影响治愈性治疗获取的医疗组织因素。
  • 采用最优匹配和层次上升分类进行纵向敏感性分析,识别两年生存率高的治愈性治疗患者亚组。

主要发现

  • 共识别19,825例新发胆道癌患者和三条临床诊疗路径:姑息治疗路径7669例(38.7%)、非治愈性治疗路径7721例(38.9%)、治愈性治疗路径4435例(22.4%)。
  • 1200家参与胆道癌治疗的中心中,低容量中心(<15例/年)占84%,中容量中心(15-30例/年)占11%,高容量中心(>30例/年)占5%。
  • 学术中心(aOR 2.32;95%CI 1.98-2.71)、私立中心(aOR 2.51;95%CI 2.22-2.83)、半私立中心(aOR 2.25;95%CI 1.91-2.65)、高容量中心(aOR 2.09;95%CI 1.81-2.42)和中容量中心(aOR 1.49;95%CI 1.33-1.68)增加治愈性治疗路径概率。
  • 纵向聚类分析中2363例(53%)治愈性治疗路径患者两年生存率高于其余患者[96.4%(95%CI 95.1-97.6)vs 38.8%(95%CI 36.3-41.4),log-rank p<0.001]。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although the incidence of BTC is raising, national healthcare strategies to improve care lack. We aimed to explore patient clinical care pathways and strategies to improve biliary tract cancer (BTC) care. METHODS: We analysed the French National Healthcare database of all BTC inpatients between January 1, 2017 and December 31, 2021. Multinomial logistic regression adjusted odds ratios (aOR) were used to identify healthcare organisation factors that influenced access to curative care both overall and in a longitudinal sensibility analysis using optimal matching and hierarchical ascending classification to detect a subgroup of curative-care patients with a high survival over a two-year period. RESULTS: A total of 19,825 new BTC patients and three clinical care pathways (CCP) were identified: 'Palliative care' (PC-CCP), 'Non-curative Care' (NCC-CCP) and 'Curative Care' (CC-CCP) involving 7669 (38.7%), 7721 (38.9%) and 4435 (22.4%) patients respectively. Out of 1200 centers involved in BTC treatment, 84%, 11% and 5% were of low- (<15 patients/year), medium- (15-30 patients/year) and high-volume (>30 patients/year) respectively. Among patient, tumor and hospital factors, BTC management in academic (aOR: 2.32; 95%CI: 1.98-2.71), private (2.51; 2.22-2.83), semi-private (2.25; 1.91-2.65) and in high- (2.09; 1.81-2.42) or medium-volume (1.49; 1.33-1.68) centers increased probability to CC-CCP. These results were maintained in a longitudinal cluster of 2363 (53%) CC-CCP patients presenting a higher two-year survival compared with the rest [96.4% (95.1; 97.6) vs. 38.8% (36.3; 41.4), log-rank p < 0.001]. CONCLUSIONS: Among factors subject to healthcare policy improvement, the volume and type of centers managing BTC strongly influenced access to curative care.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Tzedakis S, Challine A, Katsahian S, et al. Clinical care pathways of patients with biliary tract cancer: A French nationwide longitudinal cohort study. Eur J Cancer. 2024. PMID: 38502987. doi:10.1016/j.ejca.2024.114018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。